6lhv Citations

Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.

OpenAccess logo Nucleic Acids Res 48 3328-3342 (2020)
Related entries: 6lhs, 6lhu, 6lhw

Cited: 6 times
EuropePMC logo PMID: 32002546

Abstract

Monoubiquitination of the Fanconi anemia complementation group D2 (FANCD2) protein by the FA core ubiquitin ligase complex is the central event in the FA pathway. FANCA and FANCG play major roles in the nuclear localization of the FA core complex. Mutations of these two genes are the most frequently observed genetic alterations in FA patients, and most point mutations in FANCA are clustered in the C-terminal domain (CTD). To understand the basis of the FA-associated FANCA mutations, we determined the cryo-electron microscopy (EM) structures of Xenopus laevis FANCA alone at 3.35 Å and 3.46 Å resolution and two distinct FANCA-FANCG complexes at 4.59 and 4.84 Å resolution, respectively. The FANCA CTD adopts an arc-shaped solenoid structure that forms a pseudo-symmetric dimer through its outer surface. FA- and cancer-associated point mutations are widely distributed over the CTD. The two different complex structures capture independent interactions of FANCG with either FANCA C-terminal HEAT repeats, or the N-terminal region. We show that mutations that disturb either of these two interactions prevent the nuclear localization of FANCA, thereby leading to an FA pathway defect. The structure provides insights into the function of FANCA CTD, and provides a framework for understanding FA- and cancer-associated mutations.

Reviews - 6lhv mentioned but not cited (1)

  1. Structural insight into FANCI-FANCD2 monoubiquitination. Li L, Tan W, Deans AJ. Essays Biochem 64 807-817 (2020)

Articles - 6lhv mentioned but not cited (1)

  1. Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex. Jeong E, Lee SG, Kim HS, Yang J, Shin J, Kim Y, Kim J, Schärer OD, Kim Y, Yeo JE, Kim HM, Cho Y. Nucleic Acids Res 48 3328-3342 (2020)


Reviews citing this publication (1)

  1. Fanconi anemia pathway as a prospective target for cancer intervention. Liu W, Palovcak A, Li F, Zafar A, Yuan F, Zhang Y. Cell Biosci 10 39 (2020)

Articles citing this publication (3)

  1. Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian. Lin A, Zhou N, Zhu W, Zhang J, Wei T, Guo L, Luo P, Zhang J. Cancer Cell Int 22 173 (2022)
  2. Case Reports Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report. Qian B, Leng W, Yan Z, Lu J, Chen S, Yi H, Jiang Z. Front Oncol 12 778545 (2022)
  3. Spectrum of Germline Mutations Within Fanconi Anemia-Associated Genes Across Populations of Varying Ancestry. Chan SH, Ni Y, Li ST, Teo JX, Ishak NDB, Lim WK, Ngeow J. JNCI Cancer Spectr 5 pkaa117 (2021)